Scientists Get Closer to Long-Lasting Flu Vaccine: MONDAY.


The researchers zeroed in on the stem region of HA, which connects the virus to cells. If the body could make an immune response against the HA stem, it’s problematic for the virus to escape, Wilson said. The next phase in this extensive research is to determine if this approach is effective in people, Wilson added. Animal study findings usually do not always translate to humans. Since there is more work to be done, the best goal, of course, is always to create a life-long vaccine, Wilson said. Each year in the United States, seasonal flu causes a lot more than 200,000 hospitalizations and 36,000 deaths, based on the U.S. Centers for Disease Control and Prevention. Presently, a vaccine is established each year to safeguard against the handful of flu strains that are predicted to be the most frequent during that flu season.Worsening congestive heart failing has been noticed with TNF – blocking brokers, including HUMIRA, and new onset CHF has been reported with TNF-blocking agents. Treatment with HUMIRA may bring about the formation of autoantibodies and rarely, in advancement of a lupus-like syndrome. The most typical adverse events seen in the placebo-controlled medical trials in arthritis rheumatoid were injection site reactions , upper respiratory illness , injection site pain , headaches , rash and sinusitis .